PNEUMATIC RETINOPEXY FOR GIANT RETINAL TEAR ASSOCIATED RETINAL DETACHMENT: A Retrospective Cohort Study

医学 四分位间距 视网膜脱离 回顾性队列研究 视网膜 眼科 视力 眼泪 外科 队列 玻璃体切除术 内科学
作者
Miguel Cruz-Pimentel,Mohammed Alfalah,Wei Wei Lee,Isabela Martins Melo,Jovi C. Y. Wong,Neda Pirouzmand,Aurora Pecaku,Sueellen Demian,Faryal Maniyali,Peter J. Kertes,Rajeev H. Muni
出处
期刊:Retina-the Journal of Retinal and Vitreous Diseases [Lippincott Williams & Wilkins]
标识
DOI:10.1097/iae.0000000000004344
摘要

Purpose: To report the technique and long-term outcomes of patients with giant retinal tear associated retinal detachment (GRT-RD) treated with pneumatic retinopexy (PnR). Methods: Retrospective cohort study. All patients presenting with GRT-RD with tears in the superior ten-clock hours who underwent primary PnR were included in this study. Results: 31 patients were included in the study. 61.2% (19/31) achieved PARR with PnR at 3 months and 58.0% (18/31) at the final follow-up. Patients included in this study had a median follow-up of 24 months (interquartile range 46.5). The absence of retinal tears elsewhere at baseline was associated with a final PARR of 80% (16/20) (p= 0.007). Thirteen eyes required PPV after a failed PnR. Two eyes required the intraoperative use of perfluorocarbon liquids (PFCL). No eyes required silicone oil (SO). Visual acuity improved significantly from baseline to the last follow-up. Final anatomic reattachment rate was 100% (31/31). Conclusion: For selected cases of GRT-RDs affecting the superior ten-clock hours, PnR could be a possible treatment option when patients consent to extra visits and the surgeon has substantial expertise. When lacking this extensive experience and comfort with PnR, PPV remains the treatment that is most likely to result in a primary anatomic reattachment. While this study provides guidance on PnR technique for GRT-RDs, it is essential to note that the reported PARR may be contingent on the expertise of the surgeon/center, and the authors recommend that those new to PnR first gain substantial experience in cases meeting clinical trial criteria.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
乔垣结衣应助小熊仔采纳,获得10
1秒前
css1997完成签到 ,获得积分10
2秒前
酷波er应助wjq采纳,获得10
2秒前
2秒前
3秒前
胡萝卜发布了新的文献求助10
3秒前
橙子完成签到 ,获得积分10
4秒前
munantianxia完成签到,获得积分10
5秒前
舒适绮关注了科研通微信公众号
5秒前
酷波er应助萨尔莫斯采纳,获得10
5秒前
邓娇叶发布了新的文献求助10
5秒前
ti完成签到,获得积分10
6秒前
123完成签到,获得积分10
6秒前
6秒前
光亮的幻柏完成签到,获得积分10
7秒前
领导范儿应助活泼的觅云采纳,获得10
7秒前
pluto应助科研通管家采纳,获得20
7秒前
大个应助科研通管家采纳,获得10
7秒前
在水一方应助科研通管家采纳,获得10
7秒前
李健应助科研通管家采纳,获得10
7秒前
科研通AI5应助科研通管家采纳,获得10
7秒前
大模型应助科研通管家采纳,获得10
8秒前
慕青应助科研通管家采纳,获得10
8秒前
科研通AI5应助科研通管家采纳,获得30
8秒前
小蘑菇应助科研通管家采纳,获得10
8秒前
123发布了新的文献求助10
8秒前
Zazas完成签到,获得积分10
8秒前
李慧敏完成签到,获得积分10
9秒前
damn发布了新的文献求助30
9秒前
IRIS发布了新的文献求助10
10秒前
万能图书馆应助fsz采纳,获得10
11秒前
跳跃的蝴蝶给跳跃的蝴蝶的求助进行了留言
11秒前
李健应助福西西采纳,获得30
12秒前
12秒前
12秒前
邓娇叶完成签到,获得积分10
13秒前
13秒前
weixiang完成签到,获得积分10
14秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Production Logging: Theoretical and Interpretive Elements 3000
CRC Handbook of Chemistry and Physics 104th edition 1000
Density Functional Theory: A Practical Introduction, 2nd Edition 840
J'AI COMBATTU POUR MAO // ANNA WANG 660
Izeltabart tapatansine - AdisInsight 600
Gay and Lesbian Asia 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3755395
求助须知:如何正确求助?哪些是违规求助? 3298462
关于积分的说明 10105902
捐赠科研通 3013141
什么是DOI,文献DOI怎么找? 1655012
邀请新用户注册赠送积分活动 789339
科研通“疑难数据库(出版商)”最低求助积分说明 753273